These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 36237332)
21. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling. Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer. Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198 [TBL] [Abstract][Full Text] [Related]
23. m Yuan B; Qin H; Zhang J; Zhang M; Yang Y; Teng X; Yu H; Huang W; Wang Y Front Oncol; 2022; 12():1087753. PubMed ID: 36591468 [TBL] [Abstract][Full Text] [Related]
24. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
25. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma. Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591 [TBL] [Abstract][Full Text] [Related]
26. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer. Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446 [TBL] [Abstract][Full Text] [Related]
27. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma. Zhao M; Shen S; Xue C Front Immunol; 2022; 13():805967. PubMed ID: 35401564 [TBL] [Abstract][Full Text] [Related]
28. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer. Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H PeerJ; 2023; 11():e15013. PubMed ID: 37070095 [TBL] [Abstract][Full Text] [Related]
29. Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis. Wu Y; Xu R; Wang J; Luo Z Discov Oncol; 2024 Sep; 15(1):487. PubMed ID: 39331250 [TBL] [Abstract][Full Text] [Related]
30. Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence. Li C; Zhu J; Du H; Liang C Front Oncol; 2022; 12():814912. PubMed ID: 35669428 [TBL] [Abstract][Full Text] [Related]
31. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
32. Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer. Xie LY; Huang HY; Hao YL; Yu M; Zhang W; Wei E; Gao C; Wang C; Zeng L Front Genet; 2023; 14():1067172. PubMed ID: 37007952 [No Abstract] [Full Text] [Related]
33. Pan-Cancer Molecular Characterization of m Zhu J; Xiao J; Wang M; Hu D Front Oncol; 2020; 10():618374. PubMed ID: 33585244 [TBL] [Abstract][Full Text] [Related]
34. Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence. Zhu Q; Huang X; Yu S; Shou L; Zhang R; Xie H; Liang Z; Sun X; Feng J; Duan T; Zhang M; Xiang Y; Sui X; Jin W; Yu L; Wu Q Front Genet; 2022; 13():1043297. PubMed ID: 36324506 [No Abstract] [Full Text] [Related]
35. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas. Liu S; Wang W; Zhao Y; Liang K; Huang Y Front Oncol; 2020; 10():809. PubMed ID: 32547947 [No Abstract] [Full Text] [Related]
36. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis. Gu P; Yang D; Zhu J; Zhang M; He X Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
39. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
40. RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes. Quan Y; Ping H; Wang M; Zhang X DNA Cell Biol; 2023 Sep; 42(9):563-577. PubMed ID: 37540080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]